Clinical Trials Logo
  1. Home
  2. Colorectal Adenoma
  3. NCT02226185

Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence

Colorectal Adenoma Clinical Trial

Official title:
A Randomized, Placebo-controlled, Multicenter, Prospective Clinical Study of Berberine Hydrochloride in Preventing Recurrence and Carcinogenesis After Endoscopic Removal of Colorectal Adenomas

Clinical Trial Summary

Berberine hydrochloride is a conventional component in Chinese medicine. In recent years, anticancer activity of berberine hydrochloride have been explored. The aim of this study is to investigate the effect of berberine hydrochloride on the recurrence of colorectal adenomas.

Clinical Trial Description

Colorectal adenomas are well-known to be precancerous lesions that develop into colorectal cancers on the basis of the adenoma-carcinoma sequence. The effects of screening for colorectal adenomas and removing precancerous lesions on the prevention of colorectal cancer have been established. Because of the high recurrence rates of colorectal adenomas in patients who have undergone polypectomy, the potential chemopreventive agents that may reduce the risk of colorectal adenoma recurrence need to be investigated.

Berberine hydrochloride is a conventional component in Chinese medicine. In recent years, anticancer activity of berberine hydrochloride have been explored. The aim of this study is to investigate the effect of berberine hydrochloride on the recurrence of colorectal adenomas by conducting a randomized, placebo-controlled, prospective clinical. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02226185
Study type Interventional
Source Shanghai Jiao Tong University School of Medicine
Contact
Status Completed
Phase Phase 2/Phase 3
Start date November 2014
Completion date December 29, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT04192565 - A Prospective Investigation of the ColubrisMX ELS System N/A
Completed NCT04516785 - Reducing Colonoscopies in Patients Without Significant Bowel Disease
Recruiting NCT05381792 - Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia
Withdrawn NCT05606081 - Predicting Risk for Post-polypectomy Colorectal Cancer N/A
Recruiting NCT05576506 - Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy
Active, not recruiting NCT03796884 - Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer Phase 2
Completed NCT05508503 - A Study on a Blood-based Dual-target Test for CRC Detection
Recruiting NCT02935049 - Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique N/A
Completed NCT05477836 - Feasibility and Safety of MiWEndo-assisted Colonoscopy N/A
Active, not recruiting NCT05740137 - Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy N/A
Active, not recruiting NCT05754229 - Accuracy of Real Time Characterization in Artificial Intelligence-assisted Colonoscopy N/A
Completed NCT03234725 - Analysis of New Endoscopic Features and Variable Stiffness in Colonoscopy: Prospective Randomised Trial
Completed NCT05913453 - Technical Failure During Colorectal Endoscopic Full Thickness Resection (EFTR): The "Through Thick and Thin" Study
Recruiting NCT05261932 - Research on Endoscopic Precision Biopsy.
Completed NCT02521727 - To Investigate Risk of Colorectal Neoplasms in First-degree Relatives of Patients With Non-advanced Adenomas
Completed NCT00298545 - Effect of Vitamin D and Calcium on Genes in the Colon Phase 1
Completed NCT03268655 - Ginger and Gut Microbiome (GINGER) N/A
Active, not recruiting NCT04952129 - Optimal Selenium for Bowel Polyps (OSCAR) Phase 1
Recruiting NCT04444908 - Development and Validation of an Artificial Intelligence-assisted Strategy Selection System for Colonoscopy Cleaning
Completed NCT03943758 - a Low-residue Diet for Bowel Preparation N/A